跳至主要内容
临床试验/ISRCTN67880705
ISRCTN67880705已完成未知

INdacaterol effect on Health status in COPD: A real Life patient Experience prospective observational study (INHALE)

ovartis Pharmaceuticals UK Ltd (UK)0 个研究点目标入组 200 人开始时间: 2012年5月10日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Patients with active diagnosis of COPD, confirmed by spirometry, documented in medical notes
  • 2. Patients who are newly-prescribed indacaterol as part of routine clinical practice

排除标准

  • 1. Patients who have previously received maintenance therapy for COPD symptoms e.g. Long acting beta agonists (LABAs), long acting antimuscarinics (LAMAs), LABA + inhaled corticosteroid (ICS)
  • 2. Patients unable or unwilling to consent to participation in the study
  • 3. Patients unable or unwilling to complete the study questionnaires
  • 4. Patients who have participated in any interventional clinical trial for indacaterol
  • 5. Patients who have previously been prescribed indacaterol

研究者

发起方
ovartis Pharmaceuticals UK Ltd (UK)

相似试验